Tyrosinase Terminated Phase 3 Trials for Intraocular Melanoma Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00036816Vaccine Therapy in Treating Patients With Melanoma of the Eye